Modulating the PPARgamma pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. Chang K, Delavan HM, Yip E, Kasap C, et al. Nat Commun 2025;16:8215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang K, Delavan HM, Yip E, Kasap C, et al. Modulating the PPARgamma pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. Nat Commun 2025;16:8215.
PMID: 40931013